Riskpilot← Back to searchSign inGet full accessSlutplattan CEBFO 118063 AB
ABDissolvedOrg 5568899594General medical practice activities · NACE 8621Est. 20121 employees
Revenue 2023
SEK 0
EBITDA margin
—
+45% vs 2022
Equity ratio
92.5%
Financial strength
Net profit 2023
SEK -94K
-118% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | SEK -89K | +45% |
| Net profit | SEK -94K | -118% |
| Total assets | SEK 2,6M | -4% |
| Equity | SEK 2,4M | -4% |
| Employees | 1 | — |
Legal name
Slutplattan CEBFO 118063 AB
Org number
5568899594
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 april 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Föremålet för bolagets verksamhet är att äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 1 422 | 891 | 669 | 110 | 0 |
| Staff expenses | — | — | — | −254 | −45 |
| EBITDA | 279 | 1 719 | −297 | −163 | −89 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 279 | 1 719 | −297 | −163 | −89 |
| Net financials | — | −2 | — | −1 | −5 |
| Profit before tax | 198 | 1 389 | 16 | 694 | −94 |
| Tax | −54 | −301 | −6 | −168 | −0 |
| Net profit | 144 | 1 088 | 10 | 526 | −94 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 2 841 | 3 815 | 3 050 | 2 676 | 2 579 |
| Equity | 1 474 | 2 362 | 1 972 | 2 479 | 2 385 |
| Long-term debt | 17 | 20 | 20 | 12 | 1 |
| Short-term debt | 508 | 262 | 200 | 185 | 193 |
| Total debt | 525 | 282 | 220 | 197 | 194 |
EBITDA margin
-8902300.0%
This company
15.8%
Market median
-56343771% vs market
20192023
Equity ratio
92.5%
This company
38.2%
Market median
+142% vs market
20192023
Return on equity
-4.0%
This company
18.4%
Market median
-122% vs market
20192023
Net profit margin
-9445900.0%
This company
8.1%
Market median
-116616149% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AC | Audit | 2023 |
CF Auditor Substitute | Auditor Substitute | 2023 |
| Former (1) | ||
FI Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Deputy Board Member | 2023 | |
| Chairman | 2023 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Slutplattan CEBFO 118063 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Finn Iva Maasing | Chief Executive Officer | 0 companies |
| Anna Carina Christiansson | Audit | 0 companies |
| Carl Fredrik Johan Gustav Waern | Auditor Substitute | 0 companies |
| Bo Torsten Nilsson | Board of Directors | 0 companies |
| Peter Jonas Michael Carlborg | Deputy Board Member | 0 companies |
| Bo Torsten Patrik Nilsson | Chairman | 0 companies |
| Ian Rickard Maasing | Deputy Board Member | 0 companies |